Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Other 1Genitourinary 1Dermatologic 1

Conditions

Melanoma 44Brain Neoplasms 22Carcinoma, Renal Cell 10Neoplasm Metastasis 9Sarcoma 7Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Uveal Melanoma 5Gastrointestinal Neoplasms 4Small Cell Lung Carcinoma 3Kidney Neoplasms 3Colorectal Neoplasms 3Carcinoma, Merkel Cell 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Spinal Cord Compression 2Skin Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Radiation Injuries 1

Interventions

Radiosurgery 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Radiosurgery × Dermatologic × Clear all
NCT02406183 2017-01-10

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

University Hospital, Ghent

Phase 1 Completed
13 enrolled
Dermatologic

Melanoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡